|
|
Other links at Articles > Business of Medicine |
| 1. |
Less Medicare Pain Seen for U.S. Nursing Homes
|
|
|
Nursing home stocks could get a bounce next week if feared cuts worth billions of dollars to their reimbursement rates under the U.S. Medicare insurance program for the elderly are softened. Reuters Health Information
|
| 2. |
Viread Approved for Treating Hepatitis B
|
|
|
Gilead Sciences Inc said on Monday it won U.S. approval to promote its anti-HIV drug Viread (tenofovir) for treating adults with chronic hepatitis B. Reuters Health Information
|
| 4. |
FDA Approvals: Rotarix and PegIntron/Rebetol
|
|
|
The FDA has approved an oral vaccine (Rotarix) and new recommendations for peginterferon alfa-2b (PegIntron) plus ribavirin (Rebetol) combination therapy. Medscape Medical News
|
| 5. |
Tenet to Sell Broadlane Stake, Proceeds $155 Mln
|
|
|
Hospital operator Tenet Healthcare Corp said on Monday it will sell its interest in health care services company Broadlane Inc to TowerBrook Capital Partners L.P. for proceeds of about $155 million. Reuters Health Information
|
|
|
